Mackay Shields LLC Vanda Pharmaceuticals Inc. Transaction History

Mackay Shields LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$9.32 - $12.02 $742,077 - $957,056	-79,622 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$9.66 - $12.02 $142,968 - $177,896	14,800 Added 22.83%	79,622 $911,000
Q1 2020 May 08, 2020	BUY	$7.5 - $16.8 $69,000 - $154,560	9,200 Added 16.54%	64,822 $671,000
Q4 2019 Feb 11, 2020	SELL	$12.38 - $17.47 $39,616 - $55,904	-3,200 Reduced 5.44%	55,622 $913,000
Q3 2019 Nov 01, 2019	SELL	$12.27 - $15.79 $78,528 - $101,056	-6,400 Reduced 9.81%	58,822 $781,000
Q2 2019 Aug 13, 2019	BUY	$13.37 - $18.85 $600,607 - $846,779	44,922 Added 221.29%	65,222 $919,000
Q1 2019 May 13, 2019	BUY	$17.59 - $31.05 $357,077 - $630,315	20,300 New	20,300 $373,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $257M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.